# Lansoprazole

NDC: 43598-561
Generic name: lansoprazole
Labeler / Manufacturer: Dr.Reddys Laboratories Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE
Routes: ORAL
Marketing started: 20210201
Marketing ended: 20260930
FDA application: ANDA210465

## Active ingredients

- LANSOPRAZOLE: 30 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"43598-561"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43598-561
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=656bc92a-1f95-047d-cd27-724073e63fe6